Enamine Announces Extension of Collaboration with Sanofi in Early Drug Discovery

KIEV, Ukraine--()--Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, has announced that it has extended its collaboration agreement with Sanofi, an integrated global healthcare leader. Based on the success of the collaboration to date, the extension enables Sanofi to continue to access Enamine’s in-house designed and synthesized screening compound library, and select a library subset of novel drug-like screening compounds, according to Sanofi’s research needs. Enamine’s library, which is now the industry’s most extensive range with 2,000,000 compounds, provides Sanofi with an optimal starting point for hit finding activities for multiple therapeutic targets and will be used at Sanofi’s worldwide screening facilities.

Michael Bossert, Head of Strategic Alliances at Enamine, commented: “We have worked with Sanofi since 2012 and are delighted to continue our agreement. At Enamine our focus is on the development of original and unique chemistry, and this extension reflects our scientific knowledge and ability to exceed partner expectations. The collaboration involves regular communication with Sanofi teams and is focused on facilitating the creation of new research projects to support the emergence of effective treatments for diseases.”

For more information please visit http://www.enamine.net/

ENDS

Notes to editors

About Enamine

Established in Kiev in 1991, Enamine is a leading provider of innovative screening libraries, building blocks, fragments, and comprehensive chemistry support in hit discovery and integrated drug discovery services. Enamine’s design and synthesis capabilities allow the addition of more than 250,000 new organic compounds to its catalogue each year. Enamine offers collaborative expertise to exclusively design and supply libraries of new, potentially bioactive organic compounds and building blocks. Enamine serves the pharmaceutical, agrochemical, cosmetic, nutritional and petrochemical industries.

www.enamine.net

Contacts

Media enquiries
ZymeCommunications Ltd
Lorna Cuddon, +44 (0)7811 996 942
Lorna.cuddon@zymecommunications.com
or
Enamine
Michael Bossert, +38 044 537 32 18
Head Strategic Alliances
m.bossert@enamine.net

Contacts

Media enquiries
ZymeCommunications Ltd
Lorna Cuddon, +44 (0)7811 996 942
Lorna.cuddon@zymecommunications.com
or
Enamine
Michael Bossert, +38 044 537 32 18
Head Strategic Alliances
m.bossert@enamine.net